University of North Carolina-Lineberger Comprehensive Cancer Center: Der Leads Study Published in Science Signaling
August 13, 2019
August 13, 2019
CHAPEL HILL, North Carolina, Aug. 13 -- The University of North Carolina Lineberger Comprehensive Cancer Center issued the following news:
UNC Lineberger's Channing Der, PhD, Kenan Distinguished Professor in the UNC School of Medicine Department of Pharmacology, was corresponding author of a paper published in Science Signaling.
The study identified a potential therapeutic target for patients with KRAS-mutant pancreatic ductal adenocarcinoma. Der and his colleagues desc . . .
UNC Lineberger's Channing Der, PhD, Kenan Distinguished Professor in the UNC School of Medicine Department of Pharmacology, was corresponding author of a paper published in Science Signaling.
The study identified a potential therapeutic target for patients with KRAS-mutant pancreatic ductal adenocarcinoma. Der and his colleagues desc . . .